Top Wall Street Forecasters Revamp Walgreens Expectations Ahead Of Q3 Earnings

Walgreens Boots Alliance (WBA) is scheduled to report Q3 earnings on June 26, with analysts anticipating a significant year-over-year earnings per share decline to $0.34 from $0.63, despite projected revenue growth to $36.72 billion. This outlook follows the company's recent $300 million opioid settlement. Shares closed down 0.4% on Wednesday, reflecting a cautious analyst sentiment, as several firms including Deutsche Bank and Morgan Stanley have recently downgraded ratings or cut price targets.

Analysis

Walgreens Boots Alliance faces significant headwinds ahead of its third-quarter earnings release, characterized by a sharp divergence between top-line and bottom-line expectations. While analysts project a slight year-over-year revenue increase to $36.72 billion from $36.35 billion, a more telling metric is the anticipated 46% collapse in earnings per share to $0.34 from $0.63, signaling severe margin pressure. This financial strain is compounded by a recent $300 million settlement to resolve allegations of improperly filling opioid prescriptions, a material cash outflow. The prevailing analyst sentiment is distinctly bearish, as reflected by a series of recent rating actions; Deutsche Bank downgraded the stock to Sell with a $9 price target, and Morgan Stanley maintained its Underweight rating while cutting its target to $7. Even a Neutral rating from UBS came with a price target of $10, which is below the stock's recent closing price of $11.31, underscoring a broad-based lack of conviction in the company's near-term prospects.

Key Decisions for Investors

• Investors should approach the upcoming earnings with caution, focusing on the drivers behind the projected 46% EPS decline rather than the marginal revenue growth, as profitability is the primary concern.
• Given the consensus of analyst downgrades and price targets suggesting significant downside risk—notably $7 from Morgan Stanley and $9 from Deutsche Bank—holding or initiating a long position carries elevated risk.
• Pay close attention to management's forward-looking guidance for any commentary on margin recovery strategies and the tangible impact of the $300 million legal settlement on the company's balance sheet and cash flow.